FAMAR’s Business Unit in Alimos (Athens), Greece, is a customer-focused manufacturing site specializing in the commercial production of a broad range of sterile dosage forms, including injectable ampoules and multi-dose sterile liquid eye drops. The facility covers a total area of 4,315 m2.
Combining a customer-centric approach with strong operational performance, Alimos is recognized for its high service levels, robust quality culture and commitment to regulatory excellence. The site consistently delivers safe, high-quality products while maintaining flexibility and responsiveness to customer needs.
With a proven track record of successful inspections by health authorities and customers, Alimos has established itself as a trusted manufacturing partner, offering the quality, compliance and reliability required to support pharmaceutical products throughout their lifecycle.
FACILITY FACTS
Workforce: 122 employees
Certifications: Greek HAs (EOF) 2024, Eurasian HAs 2024, Russian Authorities Inspection 2024, ISO 9001, ISO 14001, ISO 45001, Ecovadis